Allianz Asset Management’s Verona Pharma VRNA Stock Holding History

Allianz Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,400	Closed	-$4.84M	–	2101
2025 Q3	$4.84M	Buy	45,400 +32,600	+255%	+$3.4M	0.01%	1129
2025 Q2	$1.21M	Sell	12,800 -3,000	-19%	-$222K	﹤0.01%	1625
2025 Q1	$1M	Buy	15,800 +1,000	+7%	+$59.8K	﹤0.01%	1680
2024 Q4	$687K	Buy	14,800 +3,000	+25%	+$113K	﹤0.01%	1758
2024 Q3	$339K	Buy	+11,800	New	+$290K	﹤0.01%	1961

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Allianz Asset Management's VRNA Position: Q4 2025 in Review

Allianz Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 45,400 shares — an estimated $4.84M sold.

Allianz Asset Management first reported a position in VRNA in Q3 2024 and held it in 5 quarters. The position peaked at $4.84M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Allianz Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Allianz Asset Management sold 45,400 Verona Pharma shares in Q4 2025, an estimated $4.84M.
Allianz Asset Management first reported a position in Verona Pharma in Q3 2024 and held it in 5 quarters.
Allianz Asset Management's Verona Pharma position peaked at $4.84M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Allianz Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.